Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers.


Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 27 06 2018
revised: 06 09 2018
pubmed: 10 11 2018
medline: 29 7 2020
entrez: 10 11 2018
Statut: ppublish

Résumé

Influenza vaccine uptake among Canadian pregnant individuals is suboptimal. Failure to incorporate vaccination into routine prenatal care and a lack of recommendations from healthcare providers are recognized as barriers to vaccination. The aim of this study was to assess Canadian maternity care providers' knowledge, attitudes, and practices regarding influenza vaccination in pregnancy. A cross-sectional Web-based questionnaire was sent during July and August 2017 to family physicians, obstetricians-gynaecologists, midwives, pharmacists, and nurses who care for pregnant individuals. A multivariable logistic regression model was used to determine variables independently associated with providers' recommendation of the influenza vaccine in pregnancy. The analysis included 1061 providers. Most participants (85%) reported being vaccinated against influenza themselves, and 72% reported recommending the influenza vaccine to all of their pregnant patients during the previous influenza season. Participants' attitudes regarding influenza vaccination during pregnancy were generally positive: 64% strongly agreed that pregnant individuals are at an increased risk of complications from influenza, and 69% strongly agreed that it is safe to vaccinate pregnant individuals against influenza. The main determinants of participants' recommendations for influenza vaccination to all pregnant patients were following official recommendations on influenza vaccination, discussing vaccines with most or all pregnant individuals seen in their practice, and being vaccinated themselves during the previous influenza season. Enhancing influenza vaccine uptake in pregnancy is largely dependent on maternity care providers' recommendations. This study provides valuable insight on providers' knowledge, attitudes, and practices.

Identifiants

pubmed: 30409569
pii: S1701-2163(18)30703-5
doi: 10.1016/j.jogc.2018.09.007
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-488

Informations de copyright

Copyright © 2018 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Auteurs

Eve Dubé (E)

Institut national de santé publique du Québec, Québec, QC. Electronic address: eve.dube@inspq.qc.ca.

Dominique Gagnon (D)

Institut national de santé publique du Québec, Québec, QC.

Kyla Kaminsky (K)

Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON.

Courtney R Green (CR)

Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON.

Manale Ouakki (M)

Institut national de santé publique du Québec, Québec, QC.

Julie A Bettinger (JA)

Vaccine Evaluation Center, University of British Columbia, Vancouver, BC.

Nicholas Brousseau (N)

Institut national de santé publique du Québec, Québec, QC.

Eliana Castillo (E)

Cumming School of Medicine, University of Alberta, Edmonton, AB.

Natasha S Crowcroft (NS)

Public Health Ontario, Toronto, ON.

S Michelle Driedger (SM)

Department of Community Health Science, University of Manitoba, Winnipeg, MB.

Devon Greyson (D)

Vaccine Evaluation Center, University of British Columbia, Vancouver, BC.

Deshayne Fell (D)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON.

William Fisher (W)

Department of Psychology, Western University, London, ON.

Arnaud Gagneur (A)

Department of Community Health Medicine, Université de Sherbrooke, Sherbrooke, QC.

Maryse Guay (M)

Department of Community Health Medicine, Université de Sherbrooke, Sherbrooke, QC.

Donna Halperin (D)

St. Francis Xavier University, Antigonish, NS.

Scott A Halperin (SA)

Department of Pediatrics, Dalhousie University, Halifax, NS.

Shannon MacDonald (S)

School of Public Health, University of Alberta, Edmonton, AB.

Samantha B Meyer (SB)

School of Public Health, University of Waterloo, Waterloo, ON.

Nancy M Waite (NM)

School of Pharmacy, University of Waterloo, Waterloo, ON.

Kumanan Wilson (K)

Ottawa Hospital Research Institute, Ottawa, ON.

Holly O Witteman (HO)

Family Medicine Department, Université Laval, Québec, QC.

Mark Yudin (M)

St. Michael's Hospital, Toronto, ON.

Jocelynn L Cook (JL)

Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH